The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age
- PMID: 24399105
- DOI: 10.1177/0890334413517748
The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age
Abstract
Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital.
Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatally.
Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation.
Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours.
Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatally. Further research using larger samples to assess possible developmental effects over longer periods of time is required.
Keywords: breastfeeding; drug-exposed infants; infant health; substance abuse.
Similar articles
-
Maternal Buprenorphine Maintenance and Lactation.J Hum Lact. 2016 Nov;32(4):675-681. doi: 10.1177/0890334416663198. Epub 2016 Sep 26. J Hum Lact. 2016. PMID: 27563013
-
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009. J Midwifery Womens Health. 2013. PMID: 23931660
-
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.Acta Paediatr. 2013 Nov;102(11):1060-6. doi: 10.1111/apa.12378. Epub 2013 Sep 2. Acta Paediatr. 2013. PMID: 23909865
-
Nutrition, growth, and allergic diseases among very preterm infants after hospital discharge.Dan Med J. 2013 Feb;60(2):B4588. Dan Med J. 2013. PMID: 23461996 Review.
-
Breastfeeding and substance abuse.Clin Obstet Gynecol. 2013 Mar;56(1):202-11. doi: 10.1097/GRF.0b013e31827e6b71. Clin Obstet Gynecol. 2013. PMID: 23337847 Review.
Cited by
-
Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023).Breastfeed Med. 2023 Oct;18(10):715-733. doi: 10.1089/bfm.2023.29256.abm. Breastfeed Med. 2023. PMID: 37856658
-
Oxidative stress and apoptotic index modifications in the hippocampus of rat pups born to mothers exposed to buprenorphine during lactation.Toxicol Rep. 2022 Nov 19;9:2050-2054. doi: 10.1016/j.toxrep.2022.11.005. eCollection 2022. Toxicol Rep. 2022. PMID: 36518388 Free PMC article.
-
Breastfeeding and Opiate Substitution Therapy: Starting to Understand Infant Feeding Choices.Subst Abuse. 2016 Jul 12;10(Suppl 1):43-7. doi: 10.4137/SART.S34553. eCollection 2016. Subst Abuse. 2016. PMID: 27429549 Free PMC article. Review.
-
ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.Breastfeed Med. 2015 Apr;10(3):135-41. doi: 10.1089/bfm.2015.9992. Breastfeed Med. 2015. PMID: 25836677 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical